{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-377073","form_type":"8-K","ticker":"JAZZ","cik":"0001232524","company_name":"Jazz Pharmaceuticals plc","filed_at":"2026-08-31T21:21:41+00:00","discovered_at":"2026-08-31T21:24:23.547403+00:00","generated_at":"2026-08-31T21:24:44.573174+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Jazz closes $1.25B exchangeable notes offering; repurchases $225M shares","bullets":["Completed $1.25B 1.875% exchangeable senior notes due 2032, including full $150M greenshoe exercise.","Net proceeds estimated at ~$1,226.4M; intended for general corporate purposes.","Initial exchange rate 2.8150 shares per $1,000 principal; exchange price ~$355.24 (42.5% premium).","Concurrently repurchased ~$225M of ordinary shares at $249.29 via private transactions.","Notes mature Sept 15, 2032; fully and unconditionally guaranteed by Jazz on senior unsecured basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-377073","json":"https://secwatch.observer/filing/0001193125-26-377073.json","markdown":"https://secwatch.observer/filing/0001193125-26-377073.md","text":"https://secwatch.observer/filing/0001193125-26-377073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/0001193125-26-377073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/d127542d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T21:24:44.573174+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}